To understand whether this correlation is also valid in other cancers, we investigated the correlation between the CI of EGFR inhibitor/SN-38 combination with ABCG2 expression in colorectal cancer cells using data reported in the literature [24, 25]. The gene discussed is EGFR; the disease is colorectal cancer.